A Phase 3 Study to Evaluate the Safety and Efficacy of SKY0402 in Subjects Undergoing Total Knee Arthroplasty
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The primary objective is to demonstrate that SKY0402 is superior when compared to bupivacaine
HCl in the management of postoperative pain for patients undergoing total knee arthroplasty.